In our study, multi-omics analysis demonstrated a significant increase in PUS1 expression in tumor tissue compared to normal tissue, and high expression of PUS1 was indicative of a poor prognosis in NSCLC. Here, PUS1 is linked to non-small cell lung carcinoma.